Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Rekombinanter Topoisomerase II alpha Antikörper (AA 1352-1493)

Dieses Maus Monoklonal-Antikörper erkennt spezifisch Topoisomerase II alpha in IHC (f). Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7127010

Kurzübersicht für Rekombinanter Topoisomerase II alpha Antikörper (AA 1352-1493) (ABIN7127010)

Target

Alle Topoisomerase II alpha (TOP2A) Antikörper anzeigen
Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

Antikörpertyp

Recombinant Antibody

Reaktivität

  • 142
  • 63
  • 32
  • 5
  • 5
  • 3
  • 3
  • 3
  • 1
Human

Wirt

  • 104
  • 39
Maus

Klonalität

  • 91
  • 52
Monoklonal

Konjugat

  • 78
  • 9
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser Topoisomerase II alpha Antikörper ist unkonjugiert

Applikation

  • 101
  • 61
  • 52
  • 47
  • 23
  • 19
  • 14
  • 8
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
  • Bindungsspezifität

    • 18
    • 15
    • 10
    • 9
    • 8
    • 7
    • 7
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1352-1493

    Spezifität

    It recognizes a 170 kDa protein, which is identified as topoisomerase IIi±. It shows no cross-reaction with Topoisomerase II i² or I. Topo II i± plays important roles in synthesis and transcription of DNA as well as chromosomal segregation during mitosis. It is reported to be a sensitive and specific marker of late S-, G2- & M-phases in transformed and developmentally regulated normal cells. Topo II i± is also implicated in drug resistance of tumor cells and has been shown to be over-expressed in many human cancers. Decreased expression of Topo IIa is the predominant mechanism of resistance to several chemotherapeutic agents.

    Kreuzreaktivität (Details)

    Human and Mouse.

    Aufreinigung

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogen

    Recombinant human Topoisomerase II alpha fragment (aa1352-1493)

    Isotyp

    IgG1
  • Applikationshinweise

    Known_Application: Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 minutes at RT),(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95 °C followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Positive_Control: Human lymph node or tonsil.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Konservierungsmittel

    Azide free

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Haltbarkeit

    24 months
  • Target

    Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

    Andere Bezeichnung

    TOP2A

    Hintergrund

    ATP hydrolyzing DNA topoisomerase II alfa, DNA gyrase, DNA topoisomerase (ATP hydrolyzing), DNA topoisomerase 2 alpha, DNA topoisomerase II 170kD, DNA topoisomerase II alpha, DNA Topoisomerase2, TOP2A, Topoisomerase DNA II alpha 170 kDa, TP2A,Topoisomerase II alpha (Proliferation & Drug-Resistance Marker)
    Cellular localisation: Nuclear

    Molekulargewicht

    170kDa

    Gen-ID

    7153, 156346

    UniProt

    P11388

    Pathways

    Zellzyklus, Mitotic G1-G1/S Phases
Sie sind hier:
Chat with us!